Durable Vision Gains and Greater Fluid Control With Extended Faricimab Dosing vs Aflibercept in Patients With DME

home / rapid-readouts / durable-vision-gains-and-greater-fluid-control-with-extended-faricimab-dosing-vs-aflibercept-in

In this Rapid Readout, Dr Jennifer Lim shares her presentation from the 2023 ARVO annual meeting, highlighting the visual and anatomic outcomes observed in clinical trials of faricimab when administered according to a personalized treatment algorithm for patients with diabetic macular edema (DME).

Visual and Anatomic Outcomes with Faricimab in DME Using the Treat and Extend Algorithm

EP. 1: Visual and Anatomic Outcomes with Faricimab in DME Using the Treat and Extend Algorithm

Jennifer Lim, MD, FARVO, FASRS
June 22nd 2023

Dr Jennifer Lim reviews the personalized treatment algorithm in the YOSEMITE and RHINE trials for faricimab in DME, discussing visual and anatomic outcomes with the treat and extend strategy.

Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DME

EP. 2: Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DME

Jennifer Lim, MD, FARVO, FASRS
June 22nd 2023

Dr Jennifer Lim presents two case studies demonstrating the application of the personalized treatment interval algorithm from the YOSEMITE and RHINE clinical trials for faricimab in DME.

© 2024 MJH Life Sciences

All rights reserved.